Evaluation of oral tranexamic acid in the treatment of melasma

Summary Background Melasma is an acquired, chronic, recurrent hypermelanosis that occurs exclusively in areas exposed to the sun. Its treatment can be very challenging. Tranexamic acid (TA) is an inhibitor of plasmin, and it is a synthetic derivative of the amino acid lysine that reversibly blocks b...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of cosmetic dermatology 2019-10, Vol.18 (5), p.1495-1501
Hauptverfasser:	Colferai, Mariana Morais Tavares, Miquelin, Gabriela Momente, Steiner, Denise
Format:	Artikel
Sprache:	eng
Schlagworte:	inhibitor of plasmin melanin melasma oral tranexamic acid
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!